Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now shows a 403 Forbidden error, with a standard header and footer, indicating access to the study record is blocked.SummaryDifference18%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study document revision was updated to v3.6.6 with two new update dates (2026-08-24 and 2026-08-05) and a revised file size of 1.86MB, reflecting changes to the attached document and its metadata.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays Revision: v3.6.5 in place of Revision: v3.6.4. This indicates a software/markup update to the study page.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the page template or documentation. This update does not affect the study content or data.SummaryDifference0.0%

- Check81 days agoChange DetectedThe revision label now reads v3.6.3 where it previously showed v3.6.2. This update reflects a small metadata version change and does not modify the study details.SummaryDifference0.0%

- Check88 days agoChange DetectedNew revision tag v3.6.2 has been added, replacing the previous v3.6.0. This reflects a minor update to the page’s underlying documentation/software version without changing the study content or how the page functions.SummaryDifference0.0%

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.